Detalhe da pesquisa
1.
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group.
J Clin Oncol
; 39(28): 3171-3181, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34357781